← Eichor
Study identifier: NCT07241559 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain

Condition: Chronic Low Back Pain  ·  Sponsor: Ankara City Hospital Bilkent

PhaseNA
Planned participants75
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain. -Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion. -Secondary Objective: The secondary objective is to assess the long-term effects on quality of life, proprioception, fascial thickness, and echogenicity.

This description comes directly from the study's public registry record.

Talk to the study team

Barış NACIR, Professor Doctor  ·  +905327278724  ·  drbarisnacir@gmail.com

Büşra ALÇIN, Medical Doctor  ·  +905413528952  ·  drbusraalcin@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ankara Training and Research HospitalAnkara, Altındağ, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07241559